Loading…

OK to use analytics cookies? We measure usage without cookies either way; accepting lets us see repeat visits. Declining changes nothing about how the site works. Privacy policy

Pricing About us Log in Create a free account

Directory

Every key opinion leader in the directory, every fact cited to its public source.

Showing 1–5 of 5 KOLs

Sort

Drug: Crizanlizumab✕

Kenneth Ataga, MD

University of Tennessee Health Science Center

Basic profileOncologyHematology / OncologySoutheast · TN

289
publications: 51
h-index: 2
NIH grants

View profile →

Modupe Idowu, MD

The University of Texas Health Science Center at Houston

Basic profileHematologyHematologySouth Central · TX

96
publications: 13
h-index: 1
NIH grant

View profile →

Archana Maini, MD

Broward Health Medical Center

Basic profileOncologyHematology / OncologySoutheast · FL

21
publications: 4
h-index

View profile →

Ugochi Ogu, MD

University of Tennessee Health Science Center

Basic profileOncologyHematology / OncologySoutheast · TN

45
publications: 7
h-index: 12
companies

View profile →

James Taylor, MD

Basic profileOncologyPediatric Hematology-OncologyNortheast · DC

—
publications: —
h-index: 3
companies

View profile →

findmyKOL

The world’s largest open source directory of pharma KOLs.

KOLs by therapeutic area

Oncology
Respiratory
Cardiology
Infectious Disease
Neurology
Rare/Genetic
Gastroenterology
Psychiatry
Endocrinology/Metabolic
Rheumatology/Immunology
Nephrology
Ophthalmology
Dermatology
Hematology
Epidemiology
All therapeutic areas →

KOLs by region

Northeast
West
Southeast
Midwest
South Central
All regions →

About

Directory
Institutions
Companies
About us
Blog
Pricing
Methodology
Sources
How we verify
Contact

© 2026 findmyKOL